中国实用外科杂志2017，Vol.37Issue(3)：255-258,4.DOI:10.19538/j.cjps.issn1005-2208.2017.03.11
美国癌症联合委员会甲状腺癌分期系统(第8版)更新解读
Interpretations on the updates of American Joint Committee on cancer staging system (8th edition) for thyroid cancer
孙威 1贺亮 1张浩1
作者信息
- 1. 中国医科大学附属第一医院甲状腺外科,辽宁沈阳110001
- 折叠
摘要
Abstract
American Joint Committee on Cancer (AJCC) thyroid cancer staging system, mainly consisting of the primary tumor (T), regional lymph node metastasis (N) and distant metastasis (M), is one of the most important prognostic staging systems worldwide to provide prognostic information and evaluate prognosis for thyroid cancer. In this article, we introduced the updates and interpretations of AJCC cancer staging system (8th edition) for thyroid cancer compared to the 7th edition, which consists of increasing the age at diagnosis cutoff value used for staging from 45 years to 55 years for differentiated thyroid cancer (DTC), changing the definition of T3 stage and the anaplastic thyroid cancer (ATC) T stage, changing the VII lymph node metastasis from N1b to N1a, revising the TNM staging of DTC and ATC. The new staging system not only plays an important role in the surgical treatments, but also is of great significance in evaluating the prognosis for thyroid cancer patients.关键词
甲状腺癌/美国癌症联合委员会/癌症分期系统Key words
thyroid cancer/American Joint Committee on Cancer/cancer staging system分类
医药卫生引用本文复制引用
孙威,贺亮,张浩..美国癌症联合委员会甲状腺癌分期系统(第8版)更新解读[J].中国实用外科杂志,2017,37(3):255-258,4.
